Aminocaproic Acid
"Aminocaproic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
Descriptor ID |
D015119
|
MeSH Number(s) |
D02.241.081.193.150.075 D12.125.213.075
|
Concept/Terms |
Aminocaproic Acid- Aminocaproic Acid
- 6-Aminohexanoic Acid
- 6 Aminohexanoic Acid
- epsilon-Aminocaproic Acid
- epsilon Aminocaproic Acid
- 6-Aminocaproic Acid
- 6 Aminocaproic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aminocaproic Acid".
Below are MeSH descriptors whose meaning is more specific than "Aminocaproic Acid".
This graph shows the total number of publications written about "Aminocaproic Acid" by people in this website by year, and whether "Aminocaproic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2013 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Aminocaproic Acid" by people in Profiles.
-
Nguyen TT, Lam HV, Austin TM, Stricker P, Tunceroglu H, Schoenecker J. Comparison of different dosage regimes of epsilon aminocaproic acid on blood loss in children undergoing craniosynostosis surgery. Paediatr Anaesth. 2019 08; 29(8):858-864.
-
Durkan K, Jiang Z, Rold TL, Sieckman GL, Hoffman TJ, Bandari RP, Szczodroski AF, Liu L, Miao Y, Reynolds TS, Smith CJ. A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] av?3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors. Nucl Med Biol. 2014 Feb; 41(2):133-9.
-
Gera L, Roy C, Bawolak MT, Charest-Morin X, Marceau F. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes. Peptides. 2012 Apr; 34(2):433-46.
-
Fless GM, Kirk EW, Klezovitch O, Santiago JY, Edelstein C, Hoover-Plow J, Scanu AM. Effect of phospholipase A2 digestion on the conformation and lysine/fibrinogen binding properties of human lipoprotein[a]. J Lipid Res. 1999 Apr; 40(4):583-92.
-
Klezovitch O, Edelstein C, Scanu AM. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes. J Clin Invest. 1996 Jul 01; 98(1):185-91.
-
Putnam CW, Buckley AR, Warneke JA, Karrer FM, Rhenman B, Steinbronn K. The mechanism of hepatoprotection by epsilon aminocaproic acid and putrescine. Surgery. 1984 Aug; 96(2):214-22.
-
Frederiksen MC, Bowsher DJ, Ruo TI, Henthorn TK, Ts'ao CH, Green D, Atkinson AJ. Kinetics of epsilon-aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects. Clin Pharmacol Ther. 1984 Mar; 35(3):387-93.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|